OpenAlex
PricingAboutJobs
Log inGet started
Author

Kalima Muhetaer

Institution: First Affiliated Hospital of Xinjiang Medical University
Observed institution: First Affiliated Hospital of Xinjiang Medical University
ORCID: 0009-0007-9703-1688
Observed ORCID: 0009-0007-9703-1688
OpenAlex ID: A5119329166
Efficacy and safety of PD-1 inhibitors in combination with chemotherapy as first-line treatment for HER2-negative advanced gastric or gastroesophageal junction cancer across subgroups: A comprehensive systematic review and meta-analysis
2025 · Muhetaibaier Hairoula, Yu Wei, et al. · Medicine · 2
Immunotherapy combined with chemotherapy as first-line treatment for HER2-negative advanced gastric or gastroesophageal junction cancer: systematic review and Bayesian network meta-analysis based on specific PD-L1 expression levels
2026 · Wen Yi, Kalima Muhetaer, et al. · BMC Cancer · 1
The Role of COQ10B in Tumor Progression and Its Association with Immune Escape in Esophageal Squamous Cell Carcinoma: A Multi-Omics and Functional Analysis
2026 · Leiyu Cao, Xingfang Wei, et al. · International Journal of General Medicine
The novel integrin-linked kinase inhibitor nilotinib suppresses cancer progression by promoting ubiquitylation of autoimmune regulator in oesophageal squamous cell carcinoma
2026 · Xiaoli Ma, Yu Wei, et al. · Anti-Cancer Drugs
Works count: 4
Citation count: 3
H-index: 1
I10-index:
Year
Topic
Type
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms